Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Biology and Environment (89)
- (-) National Security (33)
- (-) Neutron Science (30)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Soft Matter (1)
- Clean Energy (52)
- Climate and Environmental Systems (2)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (4)
- Fusion and Fission (3)
- Isotopes (7)
- Materials (34)
- Materials for Computing (7)
- Nuclear Science and Technology (3)
- Quantum information Science (2)
- Sensors and Controls (1)
- Supercomputing (102)
News Type
News Topics
- (-) Biomedical (24)
- (-) Clean Water (10)
- (-) Computer Science (42)
- (-) Environment (77)
- (-) Machine Learning (20)
- (-) Security (12)
- (-) Summit (15)
- 3-D Printing/Advanced Manufacturing (15)
- Advanced Reactors (2)
- Artificial Intelligence (24)
- Big Data (13)
- Bioenergy (40)
- Biology (63)
- Biotechnology (11)
- Buildings (3)
- Chemical Sciences (14)
- Climate Change (33)
- Composites (4)
- Coronavirus (18)
- Critical Materials (1)
- Cybersecurity (17)
- Decarbonization (20)
- Energy Storage (11)
- Exascale Computing (5)
- Fossil Energy (1)
- Frontier (5)
- Fusion (2)
- Grid (5)
- High-Performance Computing (23)
- Hydropower (5)
- Isotopes (2)
- Materials (22)
- Materials Science (26)
- Mathematics (3)
- Mercury (6)
- Microscopy (12)
- Molten Salt (1)
- Nanotechnology (16)
- National Security (35)
- Net Zero (2)
- Neutron Science (75)
- Nuclear Energy (6)
- Partnerships (9)
- Physics (11)
- Polymers (3)
- Quantum Computing (1)
- Quantum Science (6)
- Renewable Energy (1)
- Simulation (13)
- Space Exploration (2)
- Sustainable Energy (23)
- Transformational Challenge Reactor (1)
- Transportation (6)
Media Contacts
Scientists at the Department of Energy’s Oak Ridge National Laboratory are working to understand both the complex nature of uranium and the various oxide forms it can take during processing steps that might occur throughout the nuclear fuel cycle.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.